Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 329

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

Open access
Morris, Eva J A, Goldacre, Raphael, Spata, Enti, Mafham, Marion, Finan, Paul J, Shelton, Jon, Richards, Mike, Spencer, Katie, Emberson, Jonathan, Hollings, Sam, Curnow, Paula, Gair, Dominic, Sebag-Montefiore, David, Cunningham, Chris, Rutter, Matthew D, Nicholson, Brian D, Rashbass, Jem, Landray, Martin, Collins, Rory, Casadei, Barbara, Baigent, Colin·2021·The Lancet Gastroenterology & Hepatology

Abstract

BACKGROUND: There are concerns that the COVID-19 pandemic has had a negative effect on cancer care but there is little direct evidence to quantify any effect. This study aims to investigate the impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England. METHODS: Data were extracted from four population-based datasets spanning NHS England (the National Cancer Cancer Waiting Time Monitoring, Monthly Diagnostic, Secondary Uses Service Admitted Patient Care and the National Radiotherapy datasets) for all referrals, colonoscopies, surgical procedures, and courses of rectal radiotherapy from Jan 1, 2019, to Oct 31, 2020, related to colorectal cancer in England. Differences in patterns of care were investigated between 2019 and 2020. Percentage reductions in monthly numbers and proportions were calculated. FINDINGS: As compared to the monthly average in 2019, in April, 2020, there was a 63% (95% CI 53-71) reduction (from 36 274 to 13 440) in the monthly number of 2-week referrals for suspected cancer and a 92% (95% CI 89-95) reduction in the number of colonoscopies (from 46 441 to 3484). Numbers had just recovered by October, 2020. This resulted in a 22% (95% CI 8-34) relative reduction in the number of cases referred for treatment (from a monthly average of 2781 in 2019 to 2158 referrals in April, 2020). By October, 2020, the monthly rate had returned to 2019 levels but did not exceed it, suggesting that, from April to October, 2020, over 3500 fewer people had been diagnosed and treated for colorectal cancer in England than would have been expected. There was also a 31% (95% CI 19-42) relative reduction in the numbers receiving surgery in April, 2020, and a lower proportion of laparoscopic and a greater proportion of stoma-forming procedures, relative to the monthly average in 2019. By October, 2020, laparoscopic surgery and stoma rates were similar to 2019 levels. For rectal cancer, there was a 44% (95% CI 17-76) relative increase in the use of neoadjuvant radiotherapy in April, 2020, relative to the monthly average in 2019, due to greater use of short-course regimens. Although in June, 2020, there was a drop in the use of short-course regimens, rates remained above 2019 levels until October, 2020. INTERPRETATION: The COVID-19 pandemic has led to a sustained reduction in the number of people referred, diagnosed, and treated for colorectal cancer. By October, 2020, achievement of care pathway targets had returned to 2019 levels, albeit with smaller volumes of patients and with modifications to usual practice. As pressure grows in the NHS due to the second wave of COVID-19, urgent action is needed to address the growing burden of undetected and untreated colorectal cancer in England. FUNDING: Cancer Research UK, the Medical Research Council, Public Health England, Health Data Research UK, NHS Digital, and the National Institute for Health Research Oxford Biomedical Research Centre.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(21)00005-4

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 329

Metadata

Authors
Morris, E. J. A., Goldacre, R., Spata, E., Mafham, M., Finan, P. J., Shelton, J., Richards, M., Spencer, K., Emberson, J., Hollings, S., Curnow, P., Gair, D., Sebag-Montefiore, D., Cunningham, C., Rutter, M. D., Nicholson, B. D., Rashbass, J., Landray, M., Collins, R., Casadei, B., & Baigent, C.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2021-03
Volume
6
Issue
3
Pages
199-208
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3121455070
Cited by
329
References
19
FWCI
23.81
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. https://app.cochat.ai/papers/10.1016/s2468-1253(21)00005-4
The paper
Morris, E. J. A., Goldacre, R., Spata, E., Mafham, M., Finan, P. J., Shelton, J., Richards, M., Spencer, K., Emberson, J., Hollings, S., Curnow, P., Gair, D., Sebag-Montefiore, D., Cunningham, C., Rutter, M. D., Nicholson, B. D., Rashbass, J., Landray, M., Collins, R., . . . Baigent, C. (2021). Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(21)00005-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.